Muriel Sudres

Muriel Sudres is a Project Manager at the Institut Pasteur, where management includes a project focused on AAV gene therapy for hearing loss, since June 2021. Previous experience encompasses roles as Clinical Operation Manager at Krystal Biotech, Inc., where responsibilities included developing clinical study documents and supporting study logistics, and R&D Project Manager at Genethon, managing lentiviral gene therapy projects. Earlier positions include Drug Safety Officer at the Pierre Louis Institute of Epidemiology and Public Health, ensuring compliance with safety protocols, and Postdoctoral Researcher roles at both the Institut de Myologie and Genethon, conducting innovative research on cell therapy and immunogenicity. Muriel Sudres holds a PhD in Immunology from Université Paris Cité, alongside multiple relevant certifications in clinical research and drug safety.